- Faculty and Research
- Academic Divisions
- Centers and Programs
- Faculty Governance (login)
- Executive MBA
- Doctoral Program
- Master of Science
- Executive Education
- Undergraduate Concentration
- Predoctoral Research Opportunities
- Current Students
- Ideas and Insights
- About Us
- Why Columbia Business School?
- Theory to Practice
- History and Future
- Columbia Business School Board
- The Diversity, Equity, and Inclusion Initiative
- Digital Media
- Campus Map and Directions
- Contact Us
- Careers at Columbia
- Privacy and Policy Statements
- Gear Store
- For Staff
Chairman Emeritus, CR Group LP, Texas
Charles Tate previously served as chairman and founder of CR Group LP, a private equity firm targeting investments in the healthcare industry. Headquartered in Houston, the firm provides capital to the healthcare industry by acquiring royalty and net revenue interests in ethical pharmaceuticals or medical devices from royalty holders or biotechnology/pharmaceutical companies needing liquidity or capital for developmental purposes.
Mr. Tate has more than 35 years’ experience in investment and merchant banking. Prior to forming CRG, he was a partner and member of the management committee of Hicks, Muse, Tate & Furst Inc., from which he retired in June 2002. He joined Hicks Muse in 1991. Prior to that, he was at Morgan Stanley & Co. for 19 years, most of that time as a managing director in the mergers and acquisitions department, and for the last two-and-a-half years in the merchant banking area. Before joining Morgan Stanley, he was employed by the Bank of America in New York from 1968 to 1971.
Mr. Tate serves on the University Cancer Foundation board of visitors for M.D. Anderson Cancer Center and is a member of the strategic advisory committee, chairman of the Center for Global Oncology Advisory Group, and a member of the M.D. Anderson Cancer Center “Making Cancer History” Campaign Cabinet. He serves as chairman of the external advisory committee of the Department of Biomedical Engineering, a single University of Texas academic department spanning U.T. Austin’s Cockrell School of Engineering, M.D. Anderson Cancer Center, and the Health Science Center at Houston. Mr. Tate also serves on the University of Texas development board and is co–vice chair of the “Campaign for Texas.” He served during 2004 on the University of Texas Commission of 125 and was a member of its executive committee.
He also serves on the industry and community affiliates committee of the Academy of Medicine, Engineering, and Science of Texas. During 2002, he served on Governor Rick Perry’s Council for Science and Biotechnology Development and was chairman of the committee on capital formation. In 2005, Governor Perry appointed him chairman of the Texas Life Science Center of Innovation and Commercialization as part of the advisory structure for the state’s Emerging Technology Fund. In June 2008, Mr. Tate was appointed to the Cancer Prevention and Research Institute of Texas oversight committee and is chairman of the economic development and commercialization subcommittee.
Since September 2004, Mr. Tate has served as a director of the University of Texas Investment Management Co. (“UTIMCO”) and is currently chairman of the risk committee and a member of the audit and ethics committee. Since January 2008, he has served on the Robert A. Welch Foundation board of directors.
Mr. Tate received his BBA from the University of Texas at Austin in 1968 and his MBA from Columbia Business School in 1972. He was elected to the University of Texas at Austin McCombs School of Business Hall of Fame in 2003, and in 2007 he was elected a distinguished alumnus of the University of Texas.